Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
Figure 5
ROC analyses of the performance of the 4204 Da peptide, CA19-9, and CEA. (a) AUC was 0.752 for 4204 Da, 0.732 for CA19-9, and 0.608 for CEA. (b) AUC was 0.833 for 4204 Da + CA19-9, 0.708 for CA19-9 + CEA, and 0.836 for 4204 Da + CEA + CA19-9.
